<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-ijms-21-03099">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Mu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>W.</given-names>
   </name>
  </person-group>
  <article-title>Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation</article-title>
  <source>bioRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2020.01.27.921627</pub-id>
 </element-citation>
</ref>
